Frances Oldham Kelsey papers, 1890-2016 (Library of Congress Finding Aid)

Access restrictions apply.Some or all content stored offsite.

Container	Contents

	Part II: Subject File, 1902-2012 (continued)
BOX II:140		Enzymes, 1960-1962, 1996
BOX II:140		Epidemiology, 1962-1988, undated
BOX II:140			(3 folders)
BOX II:140		Establishment Evaluation System
BOX II:140			Division of Scientific Investigations, flow charts and milestones, circa 1995-circa 1996
BOX II:140			General, 1995-1996
BOX II:140		Ethical consideration
BOX II:140			1965-1979
BOX II:140				(2 folders)
BOX II:141			1980-1999, undated
BOX II:141		Ethical criteria, 1960-2001, undated
BOX II:141			(5 folders)
BOX II:141		European Teratology Society, 1971-1977, 1994-2000
BOX II:141			(2 folders)
BOX II:142		Executive Women in Government, 1994-1996
BOX II:142		Exempt drugs, 1979
BOX II:142		FDA Distinguished Alumni/Professor Emeritus Policy Task Force, 1998
BOX II:142		Federal Executive Professional Association, 1979-1986, 1998
BOX II:142		Feldene (piroxicam), 1983-1986
BOX II:142		Fetus and newborn, miscellaneous, 1961-1979, 1985-1986, undated
BOX II:142			(2 folders)
BOX II:142		Fialuridine (FIAU), 1993-1994, 2001
BOX II:142		Flunixin, 1976-1977
BOX II:142		Folic acid, memorandum to John Patrick Swann with attachments, 1951-1952, 1963, 1995, undated
BOX II:143		Foreign clinical studies, U.S. Food and Drug Administration policy, 1973-1992, undated
BOX II:143			(3 folders)
BOX II:143		Foreign travel requests, 1978-1982
BOX II:143		Foreign visitors, 1963-1968, 1979-1986, 1994-1997
BOX II:143		Fraud in science, cases and publicity
BOX II:143			circa 1961-1987
BOX II:143				(4 folders)
BOX II:144			1988-1999, undated
BOX II:144				(5 folders)
BOX II:144		Freedom of Information Act, correspondence and requests
BOX II:144			1977-1980
BOX II:145			1981-1987
BOX II:145		G. D. Searle & Co.
BOX II:145			Aldactone, 1975
BOX II:145			Aspartame/NutraSweet, 1983-1996, undated
BOX II:145			Copper-7, 1988, 1997
BOX II:145			Enovid/Ovulen, 1962, 1979
BOX II:145			Searle Investigation Task Force, 1975-1976, 1982-1985
BOX II:145				(2 folders)
BOX II:145		Gene therapy, death in, 1980-1981, 1999-2000
BOX II:145		General Accounting Office
BOX II:145			Anticancer drugs, 1983
BOX II:145			General
BOX II:145				1973-1976
BOX II:146				1986-1990
BOX II:146		Generic drugs, 1987-1989
BOX II:146		Genetic factors, 1956-1990, undated
BOX II:146			(6 folders)
BOX II:146		Gerovital, 1976-1980, 1999
BOX II:146		Gibson, William C., 1957-1963, 1996-2001
BOX II:146		“Ginger jake” affair, 1991-1994
BOX II:147		Good laboratory practices
BOX II:147			1964-1981
BOX II:147				(9 folders)
BOX II:148			1982-1992, 1999, undated
BOX II:148				(5 folders)
BOX II:148		Grecu, Eugen O., informal conference at U.S. Food and Drug Administration, transcript and exhibits, 1992
BOX II:148		Griseofulvin, 1963-1974, 1982-1988, undated
BOX II:148		Guidance for Industry: Providing Adequate Clinical Evidence of Effectiveness, draft, 1997
BOX II:149		Guidelines for clinical evaluations, printed matter, 1977-1980, 1987
BOX II:149			(2 folders)
BOX II:149		Gulf War/Desert Storm, consent waivers and syndrome, 1992-2000
BOX II:149		Hayes, Arthur Hull, 1979-1983
BOX II:149			(2 folders)
BOX II:149		Hayflick, Leonard, 1978-1982
BOX II:149		Heart tonic, 1965, 1997
BOX II:149		Hensley, Michael J., 1977-1981, 1999-2000
BOX II:149		Herbal remedies
BOX II:149			1992-1999
BOX II:150			2000-2002, undated
BOX II:150		Heroin and morphine, prenatal exposure and addiction, 1958-1990, 1999-2000, undated
BOX II:150			(2 folders)
BOX II:150		Hexachloophene, 1972, 1978
BOX II:150		Hexobendine, 1973
BOX II:150		Historical material
BOX II:150			CDC capsules, press coverage, 1962
BOX II:150			Drug legislation, press coverage, 1962
BOX II:150			Federal regulations
BOX II:150				1960-1961
BOX II:150				1962
BOX II:150					(1 folder)
BOX II:151					(1 folder)
BOX II:151				1963-1979
BOX II:151					(6 folders)
BOX II:152				1980-1999, undated
BOX II:152					(5 folders)
BOX II:152			General
BOX II:152				1902, 1918, 1928, 1934-1939, 1951-1961
BOX II:152					(2 folders)
BOX II:153				1962-1964
BOX II:153					(7 folders)
BOX II:154				1965-1974
BOX II:154					(7 folders)
BOX II:155				1975-2005, undated
BOX II:155					(7 folders)
BOX II:155			Micro-Dynameters and other topics, press coverage, 1962
BOX II:156			“News Items,” 1962
BOX II:156				(2 folders)
BOX II:156		History competitions, requests for information and interviews, 1971, 1989-1999, undated
BOX II:156			(2 folders)
BOX II:156		Homeopathy, 1962-1963, 1989-1997
BOX II:156		Hydrazine sulfate, 1976-1980, 1995-2000
BOX II:156		Hyperthermia and birth defects, 1966, 1973, 1980-1983, undated
BOX II:156		Hypoglycemic oral agents, 1963-1971, 1976-1984, 1998-2000
BOX II:157		Imipramine, 1963, 1969-1976, 1986
BOX II:157		Indocin, 1966, 2000
BOX II:157		Industrial Bio-Test Laboratories, Northbrook, Ill., 1977-1983, 2000-2001
BOX II:157		Influenza epidemic of 1918, 1982, 1997-2001
BOX II:157		Informed consent and patient consent See Containers II:157-II:164, Institutional review boards and consent
BOX II:157		Insecticides See Container II:186, Pesticides and environmental hazards
BOX II:157		Institutional review boards and consent
BOX II:157			Articles and clippings
BOX II:157				1961-1993
BOX II:157					(5 folders)
BOX II:158				1996-2000, undated
BOX II:158					(3 folders)
BOX II:158			Deferred consent, 1990-1993, undated
BOX II:158				(2 folders)
BOX II:158			General
BOX II:158				1962-1973
BOX II:158					(5 folders)
Next Page »

Frances Oldham Kelsey papers, 1890-2016

Contents List